Skip to main content
. 2016 Jan 15;26(10):3327–3335. doi: 10.1007/s00330-015-4178-1

Table 1.

Demographics of the Parkinson’s disease (PD) patients and healthy controls (HCs)

Demographic PD patients (n = 24) HCs (n = 26) Analyses
Age 63.42 ± 10.82 64.88 ± 8.06 P = 0.5918, Two sample t-test
Sex (M:F) 22:2 17:9 P = 0.06, Chi squared test
Handedness (R:L) 20:4 24:2 P = 0.3293, Chi squared test
H and Y Stage 1.75 ± 0.47 NA -
UPDRS score 25.04 ± 11.01 NA -
MOCA 26.54 ± 2.01 NA -
LEDD (mg) 537.64 ± 340.69 NA -

MOCA The Montreal Cognitive Assessment, H and Y Hoehn and Yahr stage, UPDRS Unified Parkinson’s Disease Rating Scale (pre-intervention and off medication), LEDD Levodopa Equivalent Daily Dose, M male, F female, R right, L left